Lonza ~ DHAid

BASEL, SwitzerlandLonza launched its new line of vegetarian docosahexaenoic acid (DHA) products, DHAid. Through an optimized fermentation process and an improved productivity of the proprietary algal strain, the products offer improved stability and taste. New additions to the line include DHAid FNO-350 and DHAid CL-400 oil products, as well as powdered DHAid Dry.

DHAid FNO-350 is a functional nutrition oil, formulated for a variety of food applications, containing 350 mg/g of DHA. . DHAid CL-400 is a clear oil with 400 mg/g DHA; this is formulated for use in dietary supplements. Both are standardized with oleic sunflower oil and allow for a more precise calculation of the final DHA concentration in finished products. DHAid Dry is designed as a dry powder formulation for dry blends, such as special nutrition beverages.

DHAid products are produced without the use of solvents. Lonza avoids contaminants common in marine sources of DHA, such as dioxins and heavy metals due to a controlled fermentation process.

DHA contributes to cell membrane fluidity, flexibility and permeability.

Lonza is a global supplier to the pharmaceutical, health care and life science industries. In 2011, the company announced its global commercial partnership with Lipogen for rights to sell phosphatidylserine (PS) and PS-based formulations in dietary supplements, medical foods and food and beverages under the Lonza name.